Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst
24th March 2023 Uncategorised 0 Sanofi, Regeneron’s Dupixent could hit $20B in peak sales with COPD expansion: analyst
kdunleavy
Fri, 03/24/2023 – 07:30
More: Sanofi, Regeneron's Dupixent could hit B in peak sales with COPD expansion: analyst
Source: fierce